The National Institute of Pediatrics (INP) in Mexico, conducted a study on genetic markers to identify children with acute leukemia, who may suffer side effects from the medications used to treat this type of cancer.Genetic markers studies are used to identify which patients are susceptible to side effects of a drug used in chemotherapy called methotrexate, which can cause mucositis or an inflammation of the mucosa and even death.Dr.

More...